Validation of the Self-Assessment for Falls in the Elderly (SAFE) Questionnaire to Assess the Risk of Falls in People Aged 60 or Over. (SAFE)

April 29, 2025 updated by: University Hospital, Montpellier

This single-centre, cross-sectional diagnostic study will determine whether the new self-completed Self-Assessment for Falls in the Elderly (SAFE) questionnaire can classify fall-risk level (low, moderate, high) in adults ≥ 60 years as accurately as the current clinician-administered international algorithm that mixes yes/no questions with physical tests; to do so, about 300 participants will (1) sign consent, (2) answer the 5-minute SAFE, and (3) undergo guideline assessment and tests by a clinician in the same visit, after which researchers will compare SAFE and clinician results for sensitivity, specificity, and predictive values, examine agreement and correlations, and give immediate risk-based prevention advice:

  • Eligibility: men or women ≥ 60 y, stable walking/balance ≥ 1 month, able to read French and perform brief tests; legal guardianship or refusal excludes.
  • Participant tasks: complete SAFE; perform Timed Up-and-Go, 4 m gait speed, Five-Times-Sit-to-Stand and Short Physical Performance Battery (SPPB) under supervision
  • Benefits/Risks: instant personalised fall-risk feedback; SAFE is risk-free and physical tests carry only minimal supervised exertion.

Falls are a leading cause of injury and death in older adults, and current assessments require trained staff; if SAFE proves equivalent, it could enable large-scale, low-cost self-screening and support future digital monitoring tools for fall prevention.

Study Overview

Detailed Description

This single centre diagnostic accuracy study validates the Self Assessment for Falls in the Elderly (SAFE), an auto-questionnaire that converts the binary items and performance tests of the 2022 World Guidelines for Falls Prevention and Management into visual analogue scales (100 mm each). SAFE is completed without assistance in ≈ 5 min and yields a continuous score that can be stratified into low, moderate, or high fall risk categories. The reference standard is the full guideline algorithm-Three Key Questions, detailed fall history characterisation, Timed Up and Go, Five Times Sit to Stand, 4 m gait speed, and Short Physical Performance Battery-administered by a trained clinician after the participant has returned the SAFE form to prevent incorporation bias.

The study adopts a cross sectional design and will recruit 300 community dwelling adults aged ≥ 60 years attending the Geriatrics Department of Montpellier University Hospital over 6 months. Sample size (300) was calculated for expected sensitivity and specificity of 0.85, 30 % prevalence of moderate to high fall risk, 5 % absolute precision, two sided α = 0.05, and 90 % power. After informed consent and eligibility verification, participants complete a single study visit in the following order: (1) SAFE self completion, (2) guideline interview plus physical tests. No investigational product, device, imaging, or biospecimen collection is involved.

Statistical plan. For every SAFE VAS (visual analogue scale) item, optimal cut points will be derived from non parametric ROC analysis versus its binary analogue. The primary analysis compares the three level SAFE classification with the reference standard using contingency tables and reports sensitivity, specificity, positive and negative predictive values, likelihood ratios, diagnostic odds ratio, and area under the summary ROC curve with 95 % confidence intervals. Secondary analyses will explore Pearson or point biserial correlations between individual SAFE scores and continuous physical test results, apply multivariable ordinal logistic regression to evaluate whether age, sex, or comorbidity modify SAFE performance, and perform decision curve analysis to estimate net clinical benefit across plausible threshold probabilities. Missing data will be handled by complete case analysis.

Data quality and monitoring. Source data will be captured in an electronic case report form with automated range and consistency checks. The CHU Montpellier sponsor will conduct risk based on site and/or remote monitoring and centralised statistical data surveillance. All study documentation will be archived for 15 years in line with French regulations.

Ethics, safety, and dissemination. The protocol has been submitted to a French Comité de Protection des Personnes and the Agence Nationale de Sécurité du Médicament (category 3). Physical testing is performed by certified staff in a dedicated fall prevention clinic with immediate assistance available; adverse events are therefore not expected but will be recorded and reported according to Good Clinical Practice. Results-positive, negative, or inconclusive-will be published in peer reviewed journals and communicated to participants on request. Should SAFE demonstrate acceptable diagnostic accuracy, its simplicity will enable large scale, low cost self screening, integration into mobile health applications, and targeted allocation of fall prevention resources for older adults.

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Hérault
      • Montpellier, Hérault, France, 34090
        • University Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • Jean Baptiste Robiaud, MD
        • Sub-Investigator:
          • Hubert Blain, MD PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • People aged 60 or over, judged by the investigator to be in stable clinical condition as regards walking and balance for at least one month,
  • Able to perform the necessary physical assessments

Exclusion Criteria:

  • Unable, according to the investigator, to answer a self-questionnaire,
  • Patient's refusal to take part in the study
  • Absence of a caregiver if the participant is unable to answer the questionnaire alone
  • Unable to understand the information note
  • Opposition of the proxy or legal guardian if the participant is under legal protection (guardianship, curatorship, safeguard of justice)
  • Subject deprived of liberty (art. L. 1121-6) (by judicial or administrative decision, or forced hospitalization)
  • Not affiliated to a French social security scheme or beneficiary of such a scheme (L1121-8-1)
  • Participation in other research involving a period of exclusion still in progress (Article L1121-12)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fall Risk Assessment
Patients or carers over 60 consulting the geriatrics department at Montpellier University Hospital

Next, the risk of falling will be assessed by a healthcare professional using a hetero-questionnaire and physical tests, as proposed in the algorithm for global recommendations (routine care).

These tests include a detailed characterisation of the history of falls, the Timed Up and Go, the Five Times Sit to Stand, the 4 m walking speed and the Short Physical Performance Battery.

All people who agree to take part in the study will first complete the SAFE self-questionnaire (intervention).

the Self Assessment for Falls in the Elderly (SAFE), an auto-questionnaire that converts the binary items and performance tests of the 2022 World Guidelines for Falls Prevention and Management into visual analogue scales (100 mm each).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance of the SAFE Self-Assessment Questionnaire compared with the global recommendations algorithm (Hetero-administered questionnaire and physical tests). sensitivity
Time Frame: At inclusion

Based on predefined VAS thresholds in the self-questionnaire, we apply the global recommendations algorithm to classify patients into low, moderate, and high risk of falling:

High Risk: At least one of the following:

Two or more falls in the last year. One fall with injury in the last year. One fall with inability to get up in the last year. Unexplained fall in the last year. Frailty: At least three of the five Fried factors (fatigue, >5 seconds for 4 meters, >15 seconds for 5 chair lifts, >4.5 kg weight loss in one year, sedentary lifestyle).

Moderate Risk: Non-severe fall, fear of falling, or instability while walking/standing, associated with: TUG ≥ 15 seconds, or ≥ 5 seconds to walk 4 meters.

Low Risk: One non-severe fall, fear of falling, or instability, but no frailty and normal TUG (Timed Up and Go) and walking speed.

We compare the statistical performance of SAFE with the reference standard using contingency tables, reporting sensitivity

At inclusion
Performance of the SAFE Self-Assessment Questionnaire compared with the global recommendations algorithm (Hetero-administered questionnaire and physical tests). specificity
Time Frame: At inclusion

Based on predefined VAS thresholds in the self-questionnaire, we apply the global recommendations algorithm to classify patients into low, moderate, and high risk of falling:

High Risk: At least one of the following:

Two or more falls in the last year. One fall with injury in the last year. One fall with inability to get up in the last year. Unexplained fall in the last year. Frailty: At least three of the five Fried factors (fatigue, >5 seconds for 4 meters, >15 seconds for 5 chair lifts, >4.5 kg weight loss in one year, sedentary lifestyle).

Moderate Risk: Non-severe fall, fear of falling, or instability while walking/standing, associated with: TUG ≥ 15 seconds, or ≥ 5 seconds to walk 4 meters.

Low Risk: One non-severe fall, fear of falling, or instability, but no frailty and normal TUG and walking speed.

We compare the statistical performance of SAFE with the reference standard using contingency tables, reporting specificity

At inclusion
Performance of the SAFE Self-Assessment Questionnaire compared with the global recommendations algorithm (Hetero-administered questionnaire and physical tests). positive predictive values
Time Frame: At inclusion

Based on predefined VAS thresholds in the self-questionnaire, we apply the global recommendations algorithm to classify patients into low, moderate, and high risk of falling:

High Risk: At least one of the following:

Two or more falls in the last year. One fall with injury in the last year. One fall with inability to get up in the last year. Unexplained fall in the last year. Frailty: At least three of the five Fried factors (fatigue, >5 seconds for 4 meters, >15 seconds for 5 chair lifts, >4.5 kg weight loss in one year, sedentary lifestyle).

Moderate Risk: Non-severe fall, fear of falling, or instability while walking/standing, associated with: TUG ≥ 15 seconds, or ≥ 5 seconds to walk 4 meters.

Low Risk: One non-severe fall, fear of falling, or instability, but no frailty and normal TUG and walking speed.

We compare the statistical performance of SAFE with the reference standard using contingency tables, reporting positive predictive values,

At inclusion
Performance of the SAFE Self-Assessment Questionnaire compared with the global recommendations algorithm (Hetero-administered questionnaire and physical tests). negative predictive values
Time Frame: At inclusion

Based on predefined VAS thresholds in the self-questionnaire, we apply the global recommendations algorithm to classify patients into low, moderate, and high risk of falling:

High Risk: At least one of the following:

Two or more falls in the last year. One fall with injury in the last year. One fall with inability to get up in the last year. Unexplained fall in the last year. Frailty: At least three of the five Fried factors (fatigue, >5 seconds for 4 meters, >15 seconds for 5 chair lifts, >4.5 kg weight loss in one year, sedentary lifestyle).

Moderate Risk: Non-severe fall, fear of falling, or instability while walking/standing, associated with: TUG ≥ 15 seconds, or ≥ 5 seconds to walk 4 meters.

Low Risk: One non-severe fall, fear of falling, or instability, but no frailty and normal TUG and walking speed.

We compare the statistical performance of SAFE with the reference standard using contingency tables, reporting negative predictive values

At inclusion
Performance of the SAFE Self-Assessment Questionnaire compared with the global recommendations algorithm (Hetero-administered questionnaire and physical tests). likelihood ratios
Time Frame: At inclusion

Based on predefined VAS thresholds in the self-questionnaire, we apply the global recommendations algorithm to classify patients into low, moderate, and high risk of falling:

High Risk: At least one of the following:

Two or more falls in the last year. One fall with injury in the last year. One fall with inability to get up in the last year. Unexplained fall in the last year. Frailty: At least three of the five Fried factors (fatigue, >5 seconds for 4 meters, >15 seconds for 5 chair lifts, >4.5 kg weight loss in one year, sedentary lifestyle).

Moderate Risk: Non-severe fall, fear of falling, or instability while walking/standing, associated with: TUG ≥ 15 seconds, or ≥ 5 seconds to walk 4 meters.

Low Risk: One non-severe fall, fear of falling, or instability, but no frailty and normal TUG and walking speed.

We compare the statistical performance of SAFE with the reference standard using contingency tables, reporting likelihood ratios

At inclusion
Performance of the SAFE Self-Assessment Questionnaire compared with the global recommendations algorithm (Hetero-administered questionnaire and physical tests). diagnostic odds ratio
Time Frame: At inclusion

Based on predefined VAS thresholds in the self-questionnaire, we apply the global recommendations algorithm to classify patients into low, moderate, and high risk of falling:

High Risk: At least one of the following:

Two or more falls in the last year. One fall with injury in the last year. One fall with inability to get up in the last year. Unexplained fall in the last year. Frailty: At least three of the five Fried factors (fatigue, >5 seconds for 4 meters, >15 seconds for 5 chair lifts, >4.5 kg weight loss in one year, sedentary lifestyle).

Moderate Risk: Non-severe fall, fear of falling, or instability while walking/standing, associated with: TUG ≥ 15 seconds, or ≥ 5 seconds to walk 4 meters.

Low Risk: One non-severe fall, fear of falling, or instability, but no frailty and normal TUG and walking speed.

We compare the statistical performance of SAFE with the reference standard using contingency tables, reporting diagnostic odds ratio

At inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS thresholds for the self-questionnaire
Time Frame: At inclusion
In this section, for each binary question on the hetero-questionnaire or involving a physical test, we aim to determine a VAS threshold from the self-questionnaire for the corresponding question. The hetero-questionnaire measure is used as a reference measure: fear of falling, unsteadiness when standing up, unsteadiness when walking, getting up easily from a chair without using hands, walking speed, fatigue, reduction in physical activity.
At inclusion
Concordance analyses
Time Frame: At inclusion
We wish to evaluate the concordance between the SAFE self-questionnaire responses and the global recommendations algorithm hetero-assessment via the Gwet coefficient for qualitative variables and the intra-class correlation coefficient (ICC) for quantitative variables.
At inclusion
Point-biserial correlations
Time Frame: At inclusion
We wish to evaluate the correlation between the VAS of the self-questionnaire and the dichotomous variables of the hetero-questionnaire (point-biserial correlations).
At inclusion
Pearson correlation analysis
Time Frame: At inclusion
We wish to evaluate the correlation between the VAS of the self-questionnaire and the physical tests of the hetero-questionnaire (Pearson correlations).
At inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean Baptiste ROBIAUD, MD, University Hospital, Montpellier

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 2, 2025

Primary Completion (Estimated)

May 2, 2026

Study Completion (Estimated)

May 2, 2026

Study Registration Dates

First Submitted

April 29, 2025

First Submitted That Met QC Criteria

April 29, 2025

First Posted (Actual)

May 8, 2025

Study Record Updates

Last Update Posted (Actual)

May 8, 2025

Last Update Submitted That Met QC Criteria

April 29, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fall Prevention

Clinical Trials on Questionnaire and Physical Exam

Subscribe